Business
Palisade Bio to Participate in the Jefferies Global Healthcare Conference
Management presentation to take place on Thursday, June 4th at 3:45 PM ET Register for the webcast here Denver, CO, May 27, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President & Chief Medical Off
About this update from Palisade Bio, Inc.
[{"type":"image","alt":"Palisade Bio, Inc.","displaySize":"","headline":null,"caption":"Palisade Bio, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":77,"url":"https://media.zenfs.com/en/globenewswire.com/2a3a6d9c80425bf813c98abfe355e747"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/qY5T694EqWTrn9GHGZ73Lw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwOA--/https://media.zenfs.com/en/globenewswire.com/2a3a6d9c80425bf813c98abfe355e747","width":300,"height":77},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/qY5T694EqWTrn9GHGZ73Lw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwOA--/https://media.zenfs.com/en/globenewswire.com/2a3a6d9c80425bf813c98abfe355e747","width":300,"height":77}},"lazy":false},{"type":"text","content":"Management presentation to take place on Thursday, June 4th at 3:45 PM ET","length":73,"tagName":"p"},{"type":"text","content":"Register for the webcast here","length":29,"tagName":"p"},{"type":"text","content":"Denver, CO, May 27, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President & Chief Medical Officer, will present at the Jefferies Global Healthcare Conference, being held June 2-4, 2026, in New York, New York.","length":520,"tagName":"p"},{"type":"text","content":"The Company’s presentation is scheduled for Thursday, June 4, 2026, at 3:45 PM ET. A live webcast of the presentation will be accessible on the Events page in the Investors section of the Company’s website at palisadebio.com. A replay will be available following the live event and will be archived for a limited time.","length":318,"tagName":"p"},{"type":"text","content":"In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered for the conference.","length":187,"tagName":"p"},{"type":"text","content":"About Palisade Bio","length":18,"tagName":"p"},{"type":"text","content":"Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company advancing a next-generation oral PDE4 inhibitor prodrug designed to im...